Call For Papers
The ICMII aims to explore emerging trends and future directions in research and innovation. It provides a collaborative platform for researchers and professionals to share ideas that shape the future of their respective domains.
The conference highlights advancements in Immunometabolism, encouraging innovative, solution-oriented research that addresses global challenges and technological evolution.
Authors are invited to submit papers addressing, but not limited to, the following areas:
- Innovations in metabolic immunotherapy
- Targeting metabolism in cancer immunotherapy
- Metabolic reprogramming for immune enhancement
- Role of nutrients in immunotherapy efficacy
- Metabolic pathways as therapeutic targets
- Personalized immunotherapy based on metabolism
- Impact of microbiome on immunotherapy outcomes
- Combination therapies in metabolic immunotherapy
- Clinical trials in metabolic immunotherapy
- Metabolic stress responses in immunotherapy
- Innovative delivery methods for immunotherapy
- Metabolic profiling in immunotherapy patients
- Role of exercise in immunotherapy success
- Ethical considerations in immunotherapy research
- Public health implications of immunotherapy
- Emerging technologies in metabolic immunotherapy
- Translational research in immunotherapy innovations
- Patient-centered approaches in immunotherapy
- Future directions in metabolic immunotherapy
- Metabolic immunotherapy in pediatric populations
Assessment
Submissions will be assessed for originality, innovation, and relevance. Accepted papers will be presented at the conference and considered for publication opportunities in reputed academic platforms.
Registration
Participants are requested to complete the registration process following acceptance of their paper. Registration ensures inclusion in the conference schedule and official records.
Publication
All accepted manuscripts will be eligible for publication consideration in conference proceedings and associated academic journals.